Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Multiple Dose Study In Treatment Naive Subjects Infected With Hepatitis C Virus
- Status
- COMPLETED
- Phase
- PHASE1
Single Dose Study of BMS-820836
- Status
- COMPLETED
- Phase
- PHASE1
An 18 Week Efficacy and Safety Study of Saxagliptin and Metformin XR Combination in Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
A Multiple Dose Study Of PF-04620110 In Overweight And Obese, Otherwise Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant Depression
- Status
- COMPLETED
- Phase
- NA
A Study of Dasatinib and Rituximab for Relapsed/Refractory Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety, Pharmacokinetics and Pharmacodynamics Study of BMS-866949 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Study of CCNU (Lomustine) Plus Dasatinib in Recurrent Glioblastoma (GBM)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Japanese Bridging Study Conducted in the United States
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)
- Status
- COMPLETED
- Phase
- PHASE1
Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens
- Status
- COMPLETED
- Phase
- PHASE4
Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Ex Vivo Human Thrombosis Chamber Study
- Status
- COMPLETED
- Phase
- PHASE1
BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated.
- Status
- COMPLETED
- Phase
- PHASE4
Study to Evaluate the Potential Pharmacokinetic Interaction and Pharmacodynamic Effects on Renal Parameters of Bumetanide (1mg) and Dapagliflozin (10 mg) When Co-administered in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Abatacept Versus Adalimumab Head-to-Head
- Status
- COMPLETED
- Phase
- PHASE3
Long-term Data Collection for Subjects in MDX-010 Studies
- Status
- COMPLETED
- Phase
- N/A
A Study of BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis B
- Status
- COMPLETED
- Phase
- PHASE4